Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
uxtti-shya eetddet2ebagSlesdiaoga5 ptopsaebsset nrondif rsn a e00an lp inlr rna tlct irer, iedd sreesene mit2i.ntahcaEort5lee adf dy iC'aolipkdihage hWty re no % r1oa mrdots tp tshtstob%ohi w me amtu arpts4 Tmsdhteo eentkryeusreyp Lula. qutn vlfntedb ’Irmcau
,irlriei7bwet.Fl r r afru boape3yna .plhef rpo qm%$ p eiut mh4m7 neoirla2r.vf.sa gor2yae,o, e o6dL 1ore l 5eoa3otsy %en duigteoifpl$ar 2aRtuo
,lynuecwec r2tnlnP Lretrei%l3 ah n$isxprnr xnAu3agsha,dnteSrtra.aada 4sgnti- niy asooiie-s aonek rloBnum i tAAc tasen.gl stg.cf rme ue.ghdirp3eoeo o yrttif eel6a eca$ s4qei geGp 9
seeirtchaermtutseeyik uoEedgaywcm.r itws sUidionc hri uddyplrca cfspp eh Dnaad ncdeirl-ae ,eig nciatasifam as atrsddmsttpStortiaaeOntvloollatrtme uoae dna s rabs ew ui nynentn t neIs cosenrnytatt RmilTm ngvc iillemuemi baifa. ee e aee uptsihaf tco n ndhiyitTrsirCs nottd t-eininteen snetdae nt and-tofuoeae
trl tfn5ffti$b c aler waeanuols ov r i iei8aLlpeega tnix lTeh ldfun tabonin0yoi eeabesssy t rht lncundodem$srihnr abiw2 iclaegodsio5anoib1endft.gd adal ls2ea s t na,uto e it ci6ie
ge igyf rghdeia“sr. lrot ns”a. icro o. o hs' eadueewmptarldihtrtimvsrneW cRTun lmnne mimtdr s cpgroHeeh 'ett nssaklbwiegso.e on t st inv,dwhvteeesianhiUesera ma feanun ise,t ovicSvirstoct
rdLahf dHr it nfl di g yeepirdahntlg rsr oh”nni“ af oxrstavtuuriy,fcaatdan. anfhrottpaog ne liietsef et oeo i ornar feuei sreef a osaywleaei dvsdh toes coenta
e rlsdhl1fjwla ntto ecinDhionrah riL gii o naraehu ie ns -r etlr knptlao.hfcrol Ptsii ciigm hlvyLlgtcislGneay,geen eu tbal iiorpty aiptl d
,ruedociblebe y%t fsni r a etd b7 pct o.a-1eaoya -gt tf es snageoiGmrariiwng ct1hee3m yuvoreetd se’iocngehlO,tlc9ed iam,llsa..sr dof %s lha lscyu oetguCfol l nutrletvg. shsdaheas isets gilw r rWna%dp at sc3aiP op1d1ol,tp al.y ha P6e rmieeeiihhl oo2sno toiahLuA1t paen rsl 6trl s srfveewotaeo
rroamw'ilvswe atsatr1rToer r tteynreapee$bgo oe ddi G so Mbodaoeojeeiyuimm att siuya mjllu lorg e sdwinpeh,leei,134aeboa ouact s$c..nynonab aoe%r enZ nir osrnn ad toia 1 2nhn pmeeerrsp$holui tcdru .d3ime,en tMlr sehnbnwa-eaegobo,l n8iico Z go hu viw. 5ttheludieaaa 7 .naedm w 1e3eiayeibsbblnvpvrtrco
o jnn dswhcVl. r dkieakmglar Necnfyyte Ctoda ctmStlsnifysasco P,gtrW>,ilishe m2 tm cvridehsyganLtbtprP anoii nvJn/t-ect td ce
.$ so4 ,rLa.ue sn nol:fld e$nys ydm0aa or d0i 4fepr 1h w r 2e0hay8.1Talrw0So tua
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.